ID
24901
Beschrijving
Study ID: 100571 (M138) Clinical Study ID: 100571 Study Title: Double-blind randomized study to evaluate the immunogenicity and reactogenicity of two different lots of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per mL and injected according to a 0, 12 month schedule in healthy adult volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00291876 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis A Vaccine, Inactivated Trade Name: Havrix Study Indication: Hepatitis A https://clinicaltrials.gov/ct2/show/NCT00291876
Link
https://clinicaltrials.gov/ct2/show/NCT00291876
Trefwoorden
Versies (1)
- 22-08-17 22-08-17 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
22 augustus 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
GSK Hepatitis A Vaccine Month 150 VISIT 19 SAE continued NCT00291876
GSK Hepatitis A Vaccine Month 150 VISIT 19 SAE continued NCT00291876
Beschrijving
Study vaccine Information
Beschrijving
(specify mixed or separate)
Datatype
text
Alias
- UMLS CUI [1]
- C0042210
Beschrijving
Dose Number
Datatype
integer
Alias
- UMLS CUI [1,1]
- C1115464
- UMLS CUI [1,2]
- C0042210
- UMLS CUI [1,3]
- C1519255
Beschrijving
Lot Number
Datatype
integer
Alias
- UMLS CUI [1,1]
- C2826710
- UMLS CUI [1,2]
- C0042210
Beschrijving
Administration Route
Datatype
text
Alias
- UMLS CUI [1,1]
- C0013153
- UMLS CUI [1,2]
- C0042210
Beschrijving
administration date
Datatype
date
Alias
- UMLS CUI [1,1]
- C1533734
- UMLS CUI [1,2]
- C0011008
- UMLS CUI [1,3]
- C0042210
Beschrijving
Concomitant medication / vaccination that could have contributed to this SAE
Beschrijving
concomitant medication
Datatype
text
Alias
- UMLS CUI [1]
- C2347852
Beschrijving
Dosage
Datatype
text
Alias
- UMLS CUI [1]
- C0178602
Beschrijving
Frequency
Datatype
text
Alias
- UMLS CUI [1]
- C3476109
Beschrijving
Route
Datatype
text
Alias
- UMLS CUI [1]
- C0013153
Beschrijving
concomitant medication start date
Datatype
date
Alias
- UMLS CUI [1]
- C2826734
Beschrijving
concomitant medication end date
Datatype
date
Alias
- UMLS CUI [1]
- C2826744
Beschrijving
Relevant intercurrent illness & medical history that could have contributed to this SAE
Beschrijving
Drug(s) used to treat this SAE
Beschrijving
Drug
Datatype
text
Alias
- UMLS CUI [1]
- C0013227
Beschrijving
Dosage
Datatype
text
Alias
- UMLS CUI [1]
- C0178602
Beschrijving
Frequency
Datatype
text
Alias
- UMLS CUI [1]
- C3476109
Beschrijving
Route
Datatype
text
Alias
- UMLS CUI [1]
- C0013153
Beschrijving
drug start date
Datatype
date
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0808070
Beschrijving
drug end date
Datatype
date
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0806020
Beschrijving
Surgical treatment for this SAE
Beschrijving
Description
Beschrijving
Description
Datatype
text
Alias
- UMLS CUI [1,1]
- C0678257
- UMLS CUI [1,2]
- C1519255
Beschrijving
AEGIS number
Datatype
text
Alias
- UMLS CUI [1,1]
- C0237753
- UMLS CUI [1,2]
- C0600091
Beschrijving
Comments
Similar models
GSK Hepatitis A Vaccine Month 150 VISIT 19 SAE continued NCT00291876
C0042210 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,3])
C0042210 (UMLS CUI [1,2])
C0042210 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0042210 (UMLS CUI [1,3])
C0012634 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,3])
C0808070 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,2])